Aurinia Pharmaceuticals Inc. has grown revenue 27% a year over three years and 42% a year over five. Revenue growth, 3-year annual rate: +27% (Biotechnology median +21%). Revenue growth, 5-year rate: +42%, growth has slowed since the five-year average. Years of annual history on file: 8, FY2018 to FY2025, as filed.

AUPHAurinia Pharmaceuticals Inc.

HealthcareUSD

$16.54

$11.0552 weeks$18.62

Is it growing?

Is AUPH growing?

Aurinia Pharmaceuticals Inc. has grown revenue 27% a year over three years and 42% a year over five.

+27%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +42%
Revenue growth, 5-year rate · +27% over three · growth has slowed since the five-year average
Years of annual history on file: 8
Years of annual history on file · FY2018 to FY2025, as filed

Details›